Chenodesoxycholsäure

Chemical data

Formula

C24H40O4

Molecular weight

392.6 g/mol

IUPAC name

(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

SMILES

C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C

InChIKey

RUDATBOHQWOJDD-BSWAIDMHSA-N

XLogP

4.9

Polar surface area

77.8 Ų

H-bond donors

3

H-bond acceptors

4

Formal charge

0

via PubChem

Drug data · ChEMBL

Max clinical phase

Approved

Molecule type

Small molecule

First approval

1983

Admin. routes

oral

Indications

irritable bowel syndrome, Spastic paraplegia, cerebrotendinous xanthomatosis, inborn errors of metabolism

via ChEMBL · EBI

• Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety.Annals of internal medicine · 1981
• Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.Seminars in liver disease · 1983
• Chenodiol and gallstones.Annals of internal medicine · 1982
• Chenodeoxycholic acid.Lancet (London, England) · 1978
• Chenodiol for dissolving gallstones.The Medical letter on drugs and therapeutics · 1983

via PubMed

Wikidata facts

Subclass of

sterol

Has part

oxygen

Mass

392.293

Has use

medication

via Wikidata · CC0